“In hypertension, getting the patients to take their medication is the most important thing you can do. I always say that any drug I can get the patient to take is the right medication. A lot of us like to use ARBs because they have minimal side effects,” said Dr. Bove, a cardiologist at Temple University, Philadelphia.
The Kyoto Heart Study was funded by Kyoto Prefectural University. Dr. Matsubara and Dr. Ruschitzka reported having no financial conflicts of interest regarding their presentations.
The 45% decrease with valsartan was driven by risk reductions of 55% for stroke and 49% for angina.
Source DR. MATSUBARA